Home
Conditions
Congenital Abnormalities

Clinical trial condition

Congenital Abnormalities

Explore clinical trials studying Congenital Abnormalities. Study availability and eligibility vary by location and protocol.

577 public trials 53 recruiting studies

Refine in advanced search Browse all conditions

Congenital Abnormalities trial results

Completed

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00112554

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View all 62 locations

View Trial Details

Completed

Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes

NCT00098423

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +58 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00079378

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +27 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

NCT00301938

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +56 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

NCT00470197

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +34 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes

NCT00331513

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Follow-up of Children With Gastrointestinal Malformations and Postnatal Surgery

NCT01451307

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, +1 more
Locations: Johann Wolfgang Goethe University Hospital, Department of Neonatology Frankfurt/M, Hesse, Germany

View Trial Details

Completed

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT00454480

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
Locations: Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

Royal United Hospital Bath, England, United Kingdom

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom

Birmingham Heartlands Hospital Birmingham, England, United Kingdom

View all 96 locations

View Trial Details

Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00304018

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +45 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00054327

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +51 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Congenital Abnormalities

Congenital Abnormalities trial results

Related conditions